An updated list of eumycetoma causative agents and their differences in grain formation and treatment response
Clinical Microbiology Reviews · 13.06.2024 · 37 (2)
DOI: 10.1128/cmr.00034-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 13.06.2024. Verfasst von Wendy W J van de Sande und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Mycetoma, Antifungal Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 293 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In 2023, the World Health Organization designated eumycetoma causative agents as high-priority pathogens on its list of fungal priority pathogens. Despite this recognition, a comprehensive understanding of these causative agents is lacking, and potential variations in clinical manifestations or therapeutic responses remain unclear. In this review, 12,379 eumycetoma cases were reviewed. In total, 69 different fungal species were identified as causative agents. However, some were only identified once, and there was no supporting evidence that they were indeed present in the grain. Madurella mycetomatis was by far the most commonly reported fungal causative agent. In most studies, identification of the fungus at the species level was based on culture or histology, which was prone to misidentifications. The newly used molecular identification tools identified new causative agents. Clinically, no differences were reported in the appearance of the lesion, but variations in mycetoma grain formation and antifungal susceptibility were observed. Although attempts were made to explore the differences in clinical outcomes based on antifungal susceptibility, the lack of large clinical trials and the inclusion of surgery as standard treatment posed challenges in drawing definitive conclusions. Limited case series suggested that eumycetoma cases caused by Fusarium species were less responsive to treatment than those caused by Madurella mycetomatis . However, further research is imperative for a comprehensive understanding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
- The Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan.
ORCID-Profile: Wendy W J van de Sande, Ahmed H Fahal
Zitieren
APA
van de Sande, W. W. J., & Fahal, A. H. (2024). An updated list of eumycetoma causative agents and their differences in grain formation and treatment response. Clinical Microbiology Reviews, 37(2). https://doi.org/10.1128/cmr.00034-23
Vancouver
van de Sande WWJ, Fahal AH. An updated list of eumycetoma causative agents and their differences in grain formation and treatment response. Clinical Microbiology Reviews. 2024;37(2). doi:10.1128/cmr.00034-23
BibTeX
@article{vandeSande2024,
author = {van de Sande, Wendy W J and Fahal, Ahmed H},
title = {An updated list of eumycetoma causative agents and their differences in grain formation and treatment response},
journal = {Clinical Microbiology Reviews},
year = {2024},
volume = {37},
number = {2},
doi = {10.1128/cmr.00034-23}
}
EUVIMED